20,873 Shares in Stereotaxis Inc. (NYSEAMERICAN:STXS) Purchased by XTX Topco Ltd

XTX Topco Ltd purchased a new position in Stereotaxis Inc. (NYSEAMERICAN:STXS) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 20,873 shares of the company’s stock, valued at approximately $37,000.

Other institutional investors also recently modified their holdings of the company. Lagoda Investment Management L.P. grew its position in Stereotaxis by 7.7% during the 4th quarter. Lagoda Investment Management L.P. now owns 4,126,135 shares of the company’s stock valued at $9,408,000 after purchasing an additional 295,700 shares during the last quarter. Essex Investment Management Co. LLC grew its position in Stereotaxis by 28.3% during the 1st quarter. Essex Investment Management Co. LLC now owns 1,556,094 shares of the company’s stock valued at $2,739,000 after purchasing an additional 343,130 shares during the last quarter. Geode Capital Management LLC grew its position in Stereotaxis by 0.6% during the 4th quarter. Geode Capital Management LLC now owns 1,399,498 shares of the company’s stock valued at $3,192,000 after purchasing an additional 7,780 shares during the last quarter. State of Wyoming grew its position in Stereotaxis by 14.8% during the 4th quarter. State of Wyoming now owns 536,698 shares of the company’s stock valued at $1,224,000 after purchasing an additional 69,259 shares during the last quarter. Finally, Northern Trust Corp grew its position in Stereotaxis by 3.6% during the 4th quarter. Northern Trust Corp now owns 480,577 shares of the company’s stock valued at $1,096,000 after purchasing an additional 16,571 shares during the last quarter. 45.35% of the stock is currently owned by institutional investors.

Stereotaxis Stock Performance

Shares of STXS stock opened at $2.73 on Friday. Stereotaxis Inc. has a one year low of $1.54 and a one year high of $2.96. The company’s 50-day moving average is $2.30 and its 200 day moving average is $2.14. The company has a market capitalization of $247.47 million, a price-to-earnings ratio of -9.41 and a beta of 1.51.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.